系统性硬化症相关的间歇性肺病的复合终点:在两个临床试验队列中与死亡率的关联
Elizabeth R Volkmann1, Holly Wilhalme2, Sam Good2
1David Geffen School of Medicine, University of California, Los Angeles, 1000 Veteran Ave. Ste 32-59, Los Angeles, CA, 90095, USA. elizabethv@elizabethvolkmann.com.
系统性硬化症相关间歇性肺病 (SSc-ILD) 试验的新组合终点,结合肺功能,成像和患者报告的结果,显示了改善的治疗效果检测,并比单独FVC更好地预测长期生存.
科学领域:
- 肺部医学 肺部医学
- 临床试验方法论 临床试验方法论
- 类风湿病学 类风湿病学
背景情况:
- 强迫生命能力 (FVC) 是系统性硬化症相关间歇性肺病 (SSc-ILD) 试验中的标准但有缺陷的终点.
- FVC受非肺部因素的影响,可能不反映患者的经验.
- 复合终点在SSc-ILD中提供了更可靠的治疗反应衡量标准.
研究的目的:
- 在外部试验队列 (SLS II) 中验证之前开发的SSc-ILD复合终点.
- 评估复合终点在SSc-ILD患者从SLS I和II中预测长期死亡率的能力.
主要方法:
- 使用SLS I数据开发了一个复合的终点,包括生理学 (FVC),放射学 (纤维化程度) 和患者报告的结果 (呼吸不良,残疾).
- 这种复合终点在外部SLS II队列中进行了后期验证.
- 考克斯的比例危险模型和日志等级测试被用来评估生存预测.
主要成果:
- 复合终点在SLS I和II中表现出比单独FVC更大的标准化效应大小.
- 复合终点在两个队列中,与FVC相比,更好地预测长期生存.
- 高复合结局得分与较差的长期存活有显著的相关性.
结论:
- 综合生理学,放射学和患者报告结果的复合终点是SSc-ILD临床试验的一个有希望的工具.
- 这种复合终点提高了统计效率和临床相关性.
- 为了广泛采用,建议进行进一步的验证研究.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
COPD: Management Using Bronchodilators and Corticosteroids
